Antoxerene
Lafayette
About Antoxerene
This is a pharmaceutical company that uses proprietary next generation screening technology to identify small molecule drugs for pathways of aging. It is an affiliate of Ichor Therapeutics. Antoxerene is eager to engage collaborators in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Seed (Aug 2017)
- Website: antoxerene.com
- Phone: +1 518 420 5004
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/antoxerene-132519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.